Health-related outcomes, health care resource utilization, and costs of multiple sclerosis in Japan compared with US and five EU countries

Health-related outcomes, health care resource utilization, and costs of multiple sclerosis in Japan compared with US and five EU countries

Kaoru Yamabe,1 Marco D DiBonaventura,2 Chris L Pashos3 1Healthcare Policy and Access, Takeda Pharmaceutical Company Limited, Chuouku, Tokyo 103-8668, Japan; 2Health Outcomes, Kantar Health, New York, NY 10010, USA; 3Global Outcomes and Epidemiology Research. Data Sciences Institute, Takeda Pharmaceu...

Full description

Bibliographic Details
Main Authors: Yamabe K, DiBonaventura MD, Pashos CL
Format: Article
Language:English
Published: Dove Medical Press 2019-01-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
Activity impairment
direct costs
healthcare resource utilization
health status
indirect costs
work productivity impairment
Online Access:https://www.dovepress.com/health-related-outcomes-health-care-resource-utilization-and-costs-of--peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/health-related-outcomes-health-care-resource-utilization-and-costs-of--peer-reviewed-article-CEOR

Similar Items